Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/18/23 16:30 | 10/16/23 | CERE | Health | Drug | Pharmaceutical Preparations | Gordon Christopher R | MA | DT | 1 | P | 125,000 | 22.81 | 0 | 5,480 | 9 | 65,683 | I | |||||||||||||||
10/18/23 16:30 | 10/16/23 | CERE | Health | Drug | Pharmaceutical Preparations | Koppel Adam | MA | DT | 1 | P | 125,000 | 22.81 | 0 | 5,480 | 9 | 65,683 | I | |||||||||||||||
10/18/23 16:30 | 10/16/23 | CERE | Health | Drug | Pharmaceutical Preparations | Bain Capital Investors LLC | MA | T | 1 | P | 125,000 | 22.81 | 0 | 5,480 | 9 | 65,680 | I | |||||||||||||||
10/17/23 16:53 | 10/16/23 | CERE | Health | Drug | Pharmaceutical Preparations | Perceptive Advisors LLC | NY | D | 1 | P | 20,000 | 22.81 | 0 | 877 | 9 | 10,965 | I | |||||||||||||||
8/7/23 17:13 | 8/3/23 | CERE | Health | Drug | Pharmaceutical Preparations | Renaud Ronald C Jr | MA | DO | P,CEO | 1 | P | 2,009 | 23.96 | 0 | 84 | 84 | I | |||||||||||||||
8/7/23 17:11 | 8/4/23 | CERE | Health | Drug | Pharmaceutical Preparations | Burgess Paul D. | MA | O | See Rema | 1 | P | 502 | 22.93 | 0 | 22 | 22 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |